Phenethyl isothiocyanate upregulates death receptors 4 and 5 , sensitizes TRAIL-induced 1 apoptosis , and inhibits proliferation in human cancer stem-like cells

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Adjuvant chemotherapy after primary treatments for cervical cancer: a critical point of view and review of the literature

  2014cited by this paper
• Phenethylisothiocyanate Alters Site- and Promoter-Specific Histone Tail Modifications in Cancer Cells

  2013cited by this paper
• Understanding and targeting cancer stem cells: therapeutic implications and challenges

  2013cited by this paper
• Salinomycin as a Drug for Targeting Human Cancer Stem Cells

  2012influential reference
• Sensitivity of a novel model of mammary cancer stem cell-like cells to TNF-related death pathways

  2012cited by this paper
• Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability

  2011influential reference
• Cisplatin and TRAIL enhance breast cancer stem cell death.

  2011cited by this paper
• Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin.

  2011cited by this paper
• Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index

  2010cited by this paper
• Dietary phenethylisothiocyanate attenuates bowel inflammation in mice

  2010cited by this paper
• Identification of selective inhibitors of cancer stem cells by high-throughput screening.

  2009cited by this paper
• Molecular crosstalk between TRAIL and natural antioxidants in the treatment of cancer

  2009cited by this paper
• Breast cancer cell growth inhibition by phenethyl isothiocyanate is associated with down-regulation of oestrogen receptor-α36

  2009cited by this paper
• Targeting protein kinase C (PKC) and telomerase by phenethyl isothiocyanate (PEITC) sensitizes PC-3 cells towards chemotherapeutic drug-induced apoptosis.

  2009cited by this paper
• The TRAIL apoptotic pathway in cancer onset, progression and therapy

  2008cited by this paper
• Plant extracts from central Asia showing antiinflammatory activities in gene expression assays

  2008cited by this paper
• TRAIL signalling: decisions between life and death.

  2007cited by this paper
• The promise of TRAIL—potential and risks of a novel anticancer therapy

  2007cited by this paper
• Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5.

  2006cited by this paper
• Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

  2006cited by this paper
• Phenethyl isothiocyanate (PEITC) inhibits growth of ovarian cancer cells by inducing apoptosis: role of caspase and MAPK activation.

  2006cited by this paper
• Sulforaphane enhances TRAIL-induced apoptosis through the induction of DR5 expression in human osteosarcoma cells.

  2006cited by this paper
• In Vitro and in Vivo Anti-Inflammatory Activity of a Seed Preparation Containing Phenethylisothiocyanate

  2006cited by this paper
• Potent chemopreventive agents against pancreatic cancer.

  2004cited by this paper
• The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors.

  2002cited by this paper
• Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update

  2002cited by this paper
• Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice.

  2002cited by this paper
• Biopharmacologic and herbal therapies for cancer: research update from NCCAM.

  2001cited by this paper
• Stem cells, cancer, and cancer stem cells

  2001cited by this paper
• Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.

  2001cited by this paper
• High-performance liquid chromatography-based determination of total isothiocyanate levels in human plasma: application to studies with 2-phenethyl isothiocyanate.

  2001cited by this paper
• Apoptosis in cancer.

  2000cited by this paper
• Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

  1999cited by this paper
• Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity.

  1998cited by this paper
• Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors.

  1997cited by this paper
• Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death.

  1996cited by this paper
• Identification and characterization of a new member of the TNF family that induces apoptosis.

  1995cited by this paper
• Tumor necrosis factor Characterization at the molecular, cellular and in vivo level

  1991cited by this paper
• Glucosinolates and their breakdown products in food and food plants.

  1983cited by this paper

• No citing papers are available for this paper.